SEC Form D private-offering filing

EPALEX Corp

A new SEC Form D private-offering notice from Mountain View, CA, a $3,199,991 filer-stated offering target in Biotech. The source filing is one click away.

EPALEX Corp site↗ Verified via SEC Form D

Clinical-stage pharmaceutical company developing novel therapies for migraine and drug-resistant epilepsy.

Filed 2025-11-10Filed to raise $3,199,991First money in 2025-10-31Raised so far $1,200,000HQ (as filed) Mountain View, CASector Biotech Stage (inferred) SeedCall status Call-ready
Source linked the Form D on EDGAR↗Website verified epalex.com↗Named in the filing 5 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.